why choose us

First received: December 16, 2022

Clinical Trial: Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Study Status: Completed

Recruit Status: Completed

Condition: Age-Related Macular Degeneration

Study Type: Observational


Official Title: Seven-year Outcomes Following Intensive Anti-vascular Endothelial Growth Factor Therapy in Patients With Exudative Age-related Macular Degeneration

Brief Summary: The aim of this study was to assess long-term benefits of intensive aflibercept and ranibizumab anti-VEGF therapy in patients with exudative AMD.

Read more